Skip to Content
The Chicago-based biopharmaceutical firm is off to a good start in 2020, having posted another quarter of expectation-beating earnings while enjoying record sales of the world’s best selling drug, Humira. While the growth of biosimilar drugs threatens its Humira franchise in the long term, AbbVie is nurturing other potential blockbusters, including immunology drug Skyrizi. The company also received FDA approval to acquire Botox-maker Allergan, which will provide a booster shot to revenue. AbbVie recently noted the pandemic has reduced prescriptions as a result of a decline in doctor’s office visits, but said it expects this trend to reverse in coming months.
Lists ranking AbbVie
Fortune 500 - 2020This year's Fortune 500 marks the 66th running of ...READ MORE
10 Best Workplaces in Biotechnology and Pharmaceuticals - 2020The best workplaces in healthcare and biopharma ma...READ MORE
100 Best Companies to Work For - 2020Our 2020 list of the 100 best companies as ranked ...READ MORE
World’s Most Admired Companies - 2020For an astounding 13th straight year, Apple claims...READ MORE
The 100 Best Workplaces for Diversity - 2019These 100 U.S. companies are doing the most to wel...READ MORE
World’s 25 Best Workplaces - 2019Companies on this year's list earned national reco...READ MORE
75 Best Large Workplaces for Women - 2019At the Best Workplaces for Women, company leaders ...READ MORE
Global 500 - 2019This year's Global 500 generated $27.7 trillion in...READ MORE
75 Best Large Workplaces for Millennials - 2019We surveyed tens of thousands of young employees t...READ MORE
The 50 Best Workplaces for Parents - 2018Companies with flexible scheduling, supportive cow...READ MORE
Created with sketchtool.Created with sketchtool.Leads, insights, and financial data for the FORTUNE 500, FORTUNE 1000, and Global 500 companies.Purchase Now